Polyheterocyclic compounds highly potent as HCV inhibitors

Details for Australian Patent Application No. 2011209051 (hide)

Owner AB Pharma Ltd.

Inventors Zhan, Zheng-yun J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011209051

PCT Pub. Number WO2011/091757

Priority 201010101403.7 27.01.10 CN

Filing date 27 January 2011

Wipo publication date 4 August 2011

International Classifications

C07D 491/056 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/403 - condensed with carbocyclic rings, e.g. carbazole

A61P 1/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/091757 Priority application(s): WO2011/091757

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209056-Component display processing method and user device

2011209004-Phenyl C-glucoside derivatives, preparation methods and uses thereof